Decision support for acute kidney injury in the emergency room
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a decision-support tool to help emergency room doctors better detect and manage acute kidney injury (a sudden drop in kidney function). It may lead to earlier treatment and better outcomes for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are visiting the emergency department at Johns Hopkins Hospital, Bayview Medical Center, or Howard County General Hospital
- You have a blood test to measure your kidney function (serum creatinine) during the ER visit
- You must have a follow-up blood test within 72 hours to check if kidney function changes
- You do not have end-stage kidney disease or need chronic dialysis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a risk score and blood tests to predict which hospitalized patients might develop acute kidney injury (sudden kidney damage). If you are at high risk, researchers will follow you closely to see if early detection can help prevent serious kidney problems.
This study uses personalized risk information and digital tools to help people plan safe transitions after a recent hospital kidney injury. The goal is to better guide next steps and reduce the chance of future kidney problems.
This study helps families and doctors make shared decisions about starting urgent dialysis for a patient with sudden kidney failure in the ICU. It aims to improve communication and support for families during this difficult time.
This study tests whether a simple scoring tool can help doctors predict which ICU patients may develop kidney problems. It may help identify patients at risk early so they can receive closer monitoring.
This study looks at people with acute (sudden) kidney injury, based on changes in a blood test called creatinine. By tracking these patterns during hospitalization, it may help improve how acute kidney injury is identified and managed.
This trial studies whether a blood test called delta C-cistatin can help doctors predict when patients can safely stop continuous kidney dialysis after acute kidney injury.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.